The current institutional shareholding score of Vyne Therapeutics Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 33.26%, representing a quarter-over-quarter increase of 127.19%. The largest institutional shareholder is James Simons, holding a total of 15.19K shares, representing 0.05% of shares outstanding, with 3.66% decrease in holdings.